Lysosome targeted therapies in hematological malignancies. [PDF]
Manivannan MS, Peters A, Gibson SB.
europepmc +1 more source
miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape. [PDF]
Chen F+28 more
europepmc +1 more source
Cardiotoxicity of small-molecule kinase inhibitors in cancer therapy. [PDF]
Zhu S+9 more
europepmc +1 more source
Cryptic to conventional cytogenetics: Philadelphia-like ALL presenting with hypereosinophilia. [PDF]
Chahine Z+3 more
europepmc +1 more source
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia. [PDF]
Luo Z+15 more
europepmc +1 more source
Beyond expectations: investigating nilotinib's potential in attenuating neurodegeneration in alzheimer's disease. [PDF]
Tocci D+7 more
europepmc +1 more source
Emergence of clonal evolution with Philadelphia chromosome in acute myeloid leukemia after hypomethylation agents and BCL2 inhibitor treatment. [PDF]
Kao SY, Hsiao SY, Du BH, Hsiao HH.
europepmc +1 more source
Comprehensive Analysis of High-Sensitive Flow Cytometry and Molecular Mensurable Residual Disease in Philadelphia Chromosome-Positive Acute Leukemia. [PDF]
de Azambuja AP+7 more
europepmc +1 more source
Discovery of <i>N</i>-(2-Acetamidobenzo[<i>d</i>]thiazol-6-yl)-2-phenoxyacetamide Derivatives as Novel Potential BCR-ABL1 Inhibitors Through Structure-Based Virtual Screening. [PDF]
Wang S, Wang M, Li Z, Xu G, Wang D.
europepmc +1 more source
Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]
Sharma S+8 more
europepmc +1 more source